A Guide To Lower Extremity Cutaneous Manifestations In Patients With HIV Infections

Start Page:
Robert G. Smith, DPM, MSc, RPh, CPed

1. CDC. HIV/AIDS Surveillance Report, 2005. Vol. 19 Atlanta: US Department of Health Services, CDC: 2009; 1-66. Available at http://www.cdc.gov/hiv/topics/surveillance/resourcess/reports/. Accessed July 13, 2009.
2. Smith RG. The Podiatrist and the HIV/AIDS Patient. Podiatry Management 2003; 22 (2): 137-150.
3. Smith RG. Recognizing lower extremity effects of antiretroviral drugs. Podiatry Today 2008; 21: (1) 62-77.
4. Spira R, Mignard M, Doutre MS, et al. Prevalence of cutaneous disorders in apopulation of HIV-infected patients. Southwestern France, 1996. Groupe d’Epidemiologie Clinique du SIDA en Aquitaine. Arch Dermatol 1998; 134 (10): 1208-1212.
5. Costner M, Cockerell CJ. The changing spectrum of the cutaneous manifestation of HIV disease. Arch Dermatol 1998; 134 (10): 1290-1292.
6. Pallangyo KJ. Cutaneous findings associated with HIV disease including AIDS: experience from Sub Saharan Africa. Trop Doct. 1992; 22 (Suppl 1): 35-41;60.
7. Rad F, Ghader E, Moradi, G et al. The relationship between skin manifestations and CD4 counts among hiv positive patients. Pak J Med Sci 2008; 24 (1): 114-117.
8. Lee D, Benson CA, Lewis CE, et al. Prevalence and factors associated with dry skin in HIV infection: the FRAM study. AIDS 2007; 21 (15): 2051-2057.
9. Nnoruka EN, Chukwuka JC, Anisuiba B. Correlation of mucocutaneous manifestation of HIV/AIDS infection with CD4 and disease progression. Int J Dermatol. 2007; 46 (Suppl 2): 14-18.
10. Josephine M, Issac E, George A, et al. Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cammeroon. Int J Dermatol 2006: 45 (3): 280-284.
11. Kaplan MH, Sadick N, McNutt NS et al. Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol 1987; 16 (3 Pt 1): 485-506.
12. Prose NS, Abson KG, Scher RK. Disorders of the nails and associated with human immunodeficiency virus infection. J Dermatol 1992; 31 (7): 453-457.
13. Scher RK, Coppa LM. Advances in the diagnosis and treatment of onychomycosis. Hosp Med 1998; 34(4):11-20.
14. Herranz P, Garcia J, De Lucas R, et al. Toenail onycomycosis in patients with acquired immune deficiency syndrome: treatment with terbinafine. Br J Dermatol. 1997; 137(4):577-580.
15. Barber K, Claveau J, Thomas R. review of treatment for onychomycosis: consideration for special populations. J Cutan Med Surg 2006; 10 (Suppl 2): S48-S53
16. De Socio GV, Simonetti S, Rosignoli D et al. Topical cidofovir for severe warts in a patient affected by AIDS and Hodgkin’s Lymphoma. Int J STD AIDS. 2008: 19 (10): 715-716.
17. Marchell NL, Lupon J, Elgart ML. Painful plaques on the soles of an HIV-positive man. Arch Dermatol. 2002; 138 (7): 973-978.
18. Wu IB, Schwartz RA. Reiter’s syndrome: the classic triad and more. J Am Acad Dermatol. 2008; 59 (1): 113-121.
19. Florrell SR. Krueger GG, Egan CA. Keratoderma Blennorrhagicum. N Engl J Med 2003; 349 (24): 2367-2368.
20. Bower M, Weir J, Francis N et al. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi’s sarcoma. AIDS 2009 June 20.
21. Smith RG. Shoe dermatitis: A review of current concepts. The Foot 2008; 18 (1): 40-47.
22. Curr N, Nixon R Allergic contact dermatitis to basic red 46 occurring in an HIV-positive patient. Australas J Dermatol. 2006; 47(3):195-7.
23. Luther J, Glesby MJ. Dermatologic adverse effects of antiretroviral therapy: recognition and management. Am J Clin Dermatol 2007; 8 (4): 221-233.
24. Rahav G, Maayan S. Nail pigmentation associated with zidovudine: a review and report of a case. Scand J Infect Dis 1992; 24 (5): 557-561.
25. Zerboni R, Angius A, Cusini M et al. Lamivudine-induced paronychia. Lancet 1998; 351(9111):1256.
26. Bouscarat F, Bouchard C, Bouhour D. Paronychia and pyogenic granuloma of the great toes in patients treated with indinavir. N Engl J Med 1998; 338(24):1776-1777.
27. Tosti A, Piraccini B, D’Antuono A, et al. Paronychia associated with antiretroviral therapy. Br J Dermatol 1999: 40(24):1165-1168 .
28. Alam M, Scher RK. Indinavir-related recurrent paronychia and ingrown toenails. Cutis 1999; 64(4):277-278.
29. Sibel S, Macher A, Goosby E.

image description image description

Anonymoussays: December 5, 2009 at 8:05 pm

Great Job by Podiatry Today :)

Reply to this comment »
Anonymoussays: December 10, 2009 at 4:46 pm

This article is a great reference. It would be nice to see more from this author. I noticed this author is not on your editorial board. Why Not ?

Nice job

Reply to this comment »

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Enter the characters shown in the image.